Your browser doesn't support javascript.
loading
Deconstructing depression and negative symptoms of schizophrenia; differential and longitudinal immune correlates, and response to minocycline treatment.
Krynicki, Carl R; Dazzan, Paola; Pariante, Carmine M; Barnes, Nicholas M; Vincent, Rachel C; Roberts, Alex; Giordano, Annalisa; Watson, Andrew; Suckling, John; Barnes, Thomas R E; Husain, Nusrat; Jones, Peter B; Joyce, Eileen; Lawrie, Stephen M; Lewis, Shôn; Deakin, Bill; Upthegrove, Rachel.
Afiliação
  • Krynicki CR; Institute for Mental Health, University of Birmingham, UK. Electronic address: c.krynicki@bham.ac.uk.
  • Dazzan P; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Pariante CM; Stress, Psychiatry and Immunology Lab & Perinatal Psychiatry, The Maurice Wohl Clinical Neuroscience Institute, King's College London, London, UK.
  • Barnes NM; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, UK.
  • Vincent RC; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, UK.
  • Roberts A; Institute of Clinical Sciences, College of Medical and Dental Sciences, University of Birmingham, UK.
  • Giordano A; Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  • Watson A; The Department of Clinical and Motor Neuroscience, UCL Queen Square Institute of Neurology, London, UK.
  • Suckling J; Brain Mapping Unit, Department of Psychiatry, Herchel Smith Building for Brain and Mind Sciences, University of Cambridge, UK; Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, UK.
  • Barnes TRE; Centre for Psychiatry, Imperial College London, London, UK.
  • Husain N; Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK; MAHSC, The University of Manchester, Manchester, UK; Lancashire & South Cumbria NHS Foundation Trust, Accrington, UK.
  • Jones PB; Brain Mapping Unit, Department of Psychiatry, Herchel Smith Building for Brain and Mind Sciences, University of Cambridge, UK; Cambridgeshire & Peterborough NHS Foundation Trust, Cambridge, UK.
  • Joyce E; The Department of Clinical and Motor Neuroscience, UCL Queen Square Institute of Neurology, London, UK.
  • Lawrie SM; Division of Psychiatry, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
  • Lewis S; Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK; MAHSC, The University of Manchester, Manchester, UK.
  • Deakin B; Division of Neuroscience and Experimental Psychology, University of Manchester, Manchester, UK.
  • Upthegrove R; Institute for Mental Health, University of Birmingham, UK; Forward Thinking Birmingham, Birmingham Women's and Children's Hospital NHS Foundation Trust, UK.
Brain Behav Immun ; 91: 498-504, 2021 01.
Article em En | MEDLINE | ID: mdl-33161162
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Minociclina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Minociclina Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article